CTSB and melanoma: These bromelain- and fastuosain-specific antibodies were cytotoxic in vitro to B16F10-Nex2 cells, suggesting that in vivo, the protective effect of these cysteine proteases against murine melanoma could be partially due to the activity of these induced antibodies.